Business Description
ProKidney Corp. is a U.S.-based medical company focused on developing cell-based treatments for people living with chronic kidney disease. Its lead treatment, rilparencel, uses a patient's own kidney cells and is currently being tested in late-stage clinical trials for advanced kidney disease and type 2 diabetes. The company has several additional related treatments at various stages of testing. Founded in 2015 and based in Winston-Salem, North Carolina, ProKidney is working to bring new options to patients with limited treatment choices for kidney disease.
